[HTML][HTML] Berberine in cardiovascular and metabolic diseases: from mechanisms to therapeutics

X Feng, A Sureda, S Jafari, Z Memariani, D Tewari… - Theranostics, 2019 - ncbi.nlm.nih.gov
Cardiovascular and metabolic diseases (CVMD) are the leading causes of death worldwide,
underscoring the urgent necessity to develop new pharmacotherapies. Berberine (BBR) is …

Berberis Vulgaris and Berberine: An Update Review

M Imenshahidi, H Hosseinzadeh - Phytotherapy research, 2016 - Wiley Online Library
Berberine is an isoquinoline alkaloid present in several plants, including Coptis sp. and
Berberis sp. Berberine is a customary component in Chinese medicine, and is characterized …

[HTML][HTML] Efficacy and safety of berberine alone for several metabolic disorders: a systematic review and meta-analysis of randomized clinical trials

Y Ye, X Liu, N Wu, Y Han, J Wang, Y Yu… - Frontiers in …, 2021 - frontiersin.org
Background: Metabolic activity is the basic life activity of organisms and the fundamental for
maintaining body functions. With the improvement of living standards, the incidence of …

[HTML][HTML] Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis

E Shantsila, PW Kamphuisen, GYH Lip - Journal of Thrombosis and …, 2010 - Elsevier
The complex and multifactorial nature of atherogenesis and development of
atherothrombotic complications involves numerous interactions between various cell types …

Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials

G Derosa, P Maffioli, AFG Cicero - Expert opinion on biological …, 2012 - Taylor & Francis
Introduction: Type 2 diabetes mellitus and hypercholesterolemia have proven to give an
increased incidence of cardiovascular diseases (CVD). Recent studies have suggested that …

Microvesicles in atherosclerosis and angiogenesis: from bench to bedside and reverse

L Badimon, R Suades, G Arderiu, E Peña… - Frontiers in …, 2017 - frontiersin.org
Atherosclerosis (AT) is a progressive chronic disease involving lipid accumulation, fibrosis,
and inflammation in medium and large-sized arteries, and it is the main cause of …

Effects of berberine on atherosclerosis

R Rui, H Yang, Y Liu, Y Zhou, X Xu, C Li… - Frontiers in …, 2021 - frontiersin.org
Atherosclerosis is an epidemic across the globe [A1], and its morbidity and mortality remain
high, involving various complications and poor prognoses. In atherosclerosis, endothelial …

Circulating endothelial and platelet derived microparticles reflect the size of myocardium at risk in patients with ST-elevation myocardial infarction

C Jung, P Sörensson, N Saleh, H Arheden, L Rydén… - Atherosclerosis, 2012 - Elsevier
OBJECTIVES: Microparticles (MP) are small membrane vesicles, released from activated,
damaged and apoptotic endothelial cells (EMP) or platelets (PMP) that may actively …

Berberine improves endothelial function by reducing endothelial microparticles-mediated oxidative stress in humans

F Cheng, Y Wang, J Li, C Su, F Wu, WH Xia… - International journal of …, 2013 - Elsevier
Abstract Background Circulating endothelial microparticles (EMPs) lead to endothelial
dysfunction by increasing oxidative stress. Berberine has a beneficial effect on endothelial …

[HTML][HTML] Cardiovascular and metabolic effects of Berberine

F Affuso, V Mercurio, V Fazio, S Fazio - World journal of cardiology, 2010 - ncbi.nlm.nih.gov
Berberine (BBR) is a natural alkaloid isolated from the Coptis Chinensis. While this plant has
been used in Ayurvedic and Chinese medicine for more than 2500 years, interest in its …